|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2025-11-05 |
$5.72 |
0.0% |
5,000
|
$28,600 |
|
Kaplan Matthew L.
|
Non-Executive Director |
Nuvectis Pharma, Inc. (NVCT)
|
2025-11-05 |
$5.84 |
0.0% |
11,000
|
$64,240 |
|
Sanchez Juan
|
Non-Executive Director |
Nuvectis Pharma, Inc. (NVCT)
|
2025-11-05 |
$5.79 |
0.0% |
13,000
|
$75,270 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-10-27 |
$6.18 |
0.0% |
154,770
|
$957,083 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-06-20 |
$7.99 |
0.0% |
5,603
|
$44,768 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-06-18 |
$8.06 |
0.0% |
33,442
|
$269,532 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-05-12 |
$8.11 |
0.0% |
21,167
|
$171,664 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-05-08 |
$8.60 |
0.0% |
27,411
|
$235,647 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2025-02-07 |
$5.00 |
0.0% |
240,000
|
$1,200,000 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2024-12-24 |
$4.65 |
0.0% |
4,500
|
$20,925 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2024-12-13 |
$4.70 |
0.0% |
17,000
|
$79,900 |
|
Poradosu Enrique
|
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2024-11-19 |
$4.99 |
0.0% |
2,000
|
$9,980 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2024-11-15 |
$4.92 |
0.0% |
20,000
|
$98,400 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-14 |
$6.74 |
-8.6% |
1,940
|
$13,076 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-10 |
$6.40 |
-3.7% |
2,000
|
$12,800 |
|
Shemesh Shay
|
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-10 |
$6.32 |
-2.5% |
1,113
|
$7,034 |
|
Poradosu Enrique
|
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-10 |
$6.29 |
-2.1% |
500
|
$3,145 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2024-03-18 |
$10.29 |
-40.1% |
5,000
|
$51,450 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-10-10 |
$11.08 |
-44.4% |
640
|
$7,091 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-10-09 |
$11.21 |
-45.0% |
1,080
|
$12,105 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-10-05 |
$11.01 |
-44.1% |
3,220
|
$35,455 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-08-16 |
$14.61 |
-57.8% |
350
|
$5,112 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-08-11 |
$14.73 |
-58.2% |
300
|
$4,418 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-31 |
$13.88 |
-55.6% |
860
|
$11,937 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-28 |
$13.91 |
-55.7% |
2,584
|
$35,943 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-27 |
$13.98 |
-55.9% |
1,556
|
$21,753 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-26 |
$13.97 |
-55.9% |
10,000
|
$139,700 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-21 |
$14.92 |
-58.7% |
335
|
$4,998 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-21 |
$14.47 |
-57.4% |
8,238
|
$119,224 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-19 |
$14.33 |
-57.0% |
200
|
$2,866 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-19 |
$14.84 |
-58.5% |
8,000
|
$118,720 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-18 |
$14.84 |
-58.5% |
9,149
|
$135,771 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-14 |
$15.52 |
-60.3% |
260
|
$4,035 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-12 |
$15.09 |
-59.2% |
3,285
|
$49,571 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-11 |
$15.36 |
-59.9% |
10,000
|
$153,600 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-07 |
$15.19 |
-59.4% |
8,948
|
$135,920 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-06 |
$14.88 |
-58.6% |
320
|
$4,762 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-07-06 |
$15.01 |
-59.0% |
3,179
|
$47,717 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-26 |
$16.50 |
-62.7% |
750
|
$12,375 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-26 |
$16.46 |
-62.6% |
16,760
|
$275,870 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-23 |
$17.43 |
-64.7% |
73,175
|
$1,275,440 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-22 |
$17.72 |
-65.2% |
13,090
|
$231,964 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-21 |
$17.88 |
-65.5% |
500
|
$8,940 |
|
Mosseri Marlio Charles
|
Non-Executive |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-15 |
$17.71 |
-65.2% |
32,124
|
$568,848 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-06-08 |
$17.45 |
-64.7% |
350
|
$6,108 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-05-31 |
$17.28 |
-64.4% |
330
|
$5,702 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-05-24 |
$17.49 |
-64.8% |
200
|
$3,498 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-05-16 |
$17.02 |
-63.8% |
320
|
$5,448 |
|
Poradosu Enrique
|
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-27 |
$11.55 |
-46.7% |
500
|
$5,775 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-23 |
$12.13 |
-49.2% |
230
|
$2,790 |
|
Shemesh Shay
|
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-21 |
$11.99 |
-48.6% |
420
|
$5,036 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-21 |
$12.08 |
-49.0% |
480
|
$5,798 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-15 |
$10.86 |
-43.3% |
2,160
|
$23,465 |
|
Shemesh Shay
|
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-15 |
$10.71 |
-42.5% |
670
|
$7,176 |
|
Shemesh Shay
|
Chief Dev. |
Nuvectis Pharma, Inc. (NVCT)
|
2022-12-21 |
$7.65 |
-19.5% |
500
|
$3,825 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-30 |
$7.45 |
-17.3% |
150
|
$1,118 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-29 |
$7.41 |
-16.9% |
450
|
$3,334 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-18 |
$7.23 |
-14.8% |
750
|
$5,425 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-17 |
$7.15 |
-13.8% |
300
|
$2,145 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-11-10 |
$7.07 |
-12.9% |
1,000
|
$7,070 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-30 |
$7.34 |
-16.1% |
1,000
|
$7,345 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-26 |
$7.85 |
-21.5% |
1,500
|
$11,775 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-23 |
$7.87 |
-21.7% |
220
|
$1,731 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-02 |
$8.29 |
-25.7% |
1,700
|
$14,099 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-02 |
$8.31 |
-25.9% |
404
|
$3,357 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-09-01 |
$8.07 |
-23.7% |
3,006
|
$24,258 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-08-29 |
$9.05 |
-31.9% |
1,500
|
$13,570 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-08-19 |
$8.69 |
-29.1% |
19,426
|
$168,725 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-08-11 |
$8.40 |
-26.7% |
19,669
|
$165,220 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-06-29 |
$11.63 |
-47.1% |
4,000
|
$46,540 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-06-24 |
$12.09 |
-49.0% |
700
|
$8,462 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-27 |
$15.82 |
-61.1% |
1,000
|
$15,820 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-20 |
$16.73 |
-63.2% |
1,200
|
$20,070 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-20 |
$16.54 |
-62.8% |
300
|
$4,962 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-18 |
$19.48 |
-68.4% |
2,010
|
$39,155 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-17 |
$19.44 |
-68.3% |
242
|
$4,704 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-16 |
$18.82 |
-67.3% |
1,700
|
$31,990 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$16.99 |
-63.7% |
12,245
|
$208,047 |
|
Shemesh Shay
|
Chief Dev |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$15.85 |
-61.1% |
1,278
|
$20,255 |
|
Hoberman Kenneth
|
Non-Executive Director |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$17.40 |
-64.6% |
6,000
|
$104,400 |
|
Kaplan Matthew L.
|
Non-Executive Director |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$16.88 |
-63.5% |
3,000
|
$50,633 |
|
Poradosu Enrique
|
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$15.33 |
-59.8% |
670
|
$10,273 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-03-28 |
$7.05 |
-12.6% |
4,000
|
$28,200 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-03-17 |
$7.63 |
-19.3% |
7,000
|
$53,410 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-14 |
$5.88 |
4.8% |
8,000
|
$47,040 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-10 |
$6.34 |
-2.8% |
8,500
|
$53,890 |
|
Bentsur Ron
|
Chairman |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-07 |
$4.96 |
24.2% |
232,500
|
$1,153,145 |
|
Shemesh Shay
|
Chief Development Officer |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-07 |
$3.41 |
80.9% |
2,946
|
$10,034 |
|
Poradosu Enrique
|
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-07 |
$3.44 |
79.0% |
4,600
|
$15,834 |